The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication

Herod, Morgan R., Adeyemi, Olueapelumi O., Ward, Joseph, Bentley, Kirsten ORCID: https://orcid.org/0000-0002-6619-2098, Harris, Mark, Stonehouse, Nicola J. and Polyak, Stephen J. 2019. The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication. Journal of General Virology 100 (9) , pp. 1293-1302. 10.1099/jgv.0.001283

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB)

Abstract

Arbidol (ARB, also known as umifenovir) is used clinically in several countries as an anti-influenza virus drug. ARB inhibits multiple enveloped viruses in vitro and the primary mode of action is inhibition of virus entry and/or fusion of viral membranes with intracellular endosomal membranes. ARB is also an effective inhibitor of non-enveloped poliovirus types 1 and 3. In the current report, we evaluate the antiviral potential of ARB against another picornavirus, foot-and-mouth disease virus (FMDV), a member of the genus Aphthovirus and an important veterinary pathogen. ARB inhibits the replication of FMDV RNA sub-genomic replicons. ARB inhibition of FMDV RNA replication is not a result of generalized inhibition of cellular uptake of cargo, such as transfected DNA, and ARB can be added to cells up to 3 h post-transfection of FMDV RNA replicons and still inhibit FMDV replication. ARB prevents the recovery of FMDV replication upon withdrawal of the replication inhibitor guanidine hydrochloride (GuHCl). Although restoration of FMDV replication is known to require de novo protein synthesis upon GuHCl removal, ARB does not suppress cellular translation or FMDV internal ribosome entry site (IRES)-driven translation. ARB also inhibits infection with the related Aphthovirus, equine rhinitis A virus (ERAV). Collectively, the data demonstrate that ARB can inhibit some non-enveloped picornaviruses. The data are consistent with inhibition of picornavirus genome replication, possibly via the disruption of intracellular membranes on which replication complexes are located.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Microbiology Society
ISSN:	0022-1317
Date of First Compliant Deposit:	24 February 2021
Date of Acceptance:	16 May 2019
Last Modified:	08 May 2023 00:06
URI:	https://orca.cardiff.ac.uk/id/eprint/138931

Citation Data

Cited 17 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item